Vaccine, 2011-10, Vol.29 (44), p.7589-7590
2011
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Response to “Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries”
- Ist Teil von
- Vaccine, 2011-10, Vol.29 (44), p.7589-7590
- Ort / Verlag
- Netherlands: Elsevier Ltd
- Erscheinungsjahr
- 2011
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- A recent supplement article by Talbird, Taylor, Knoll, Frostad, and García Martí reported estimates of public health impact and cost-effectiveness of the 10-valent pneumococcal conjugate vaccine compared with the 7-valent vaccine. Although the analysis applies a decision analytic model and modeling methodologies that are scientifically sound, many of the assumptions presented in the paper are inconsistent with the current evidence.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0264-410XeISSN: 1873-2518DOI: 10.1016/j.vaccine.2011.02.103Titel-ID: cdi_proquest_miscellaneous_903659449
- Format
- –
- Schlagworte
- Allergy and Immunology, Cost-effectiveness, Cross protection, Female, Humans, Immunization, Male, Pneumococcal conjugate vaccine, Pneumococcal Infections - epidemiology, Pneumococcal Infections - prevention & control, Pneumococcal Vaccines - economics, Pneumococcal Vaccines - immunology, Pneumonia, Prevenar, Prevenar 13, Proteins, Public health, Streptococcus pneumoniae, Vaccines